Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Completed

Trial Comparing 19 and 25-gauge EUS-FNA Needles

Multi-Center Randomized Trial Comparing 19 and 25-gauge Needles for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) of Solid Pancreatic Mass Lesions

Outcome
Results posted; no analysis attached
Phase
No phase (not a drug trial)
Status
Completed
Study type
Interventional
Start
August 2012
Ended
January 2013
Enrollment
72 participants
Sites
2
Primary outcomes
Median Number of Passes to Establish Diagnosis
Sponsor type
Academic / other
Results posted
17 March 2020
Last update
17 March 2020

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Results

Primary endpoint
Results posted; no analysis attachedAs posted on ClinicalTrials.gov ↗, registry record of 17 March 2020
Primary outcome
Median Number of Passes to Establish Diagnosis19G FNA Needle: 1 (1 to 1), n = 3625G FNA Needle: 1 (1 to 1), n = 36Values: median No. of passes, Inter-Quartile RangeTime frame: 5 monthsNo analysis posted for this outcome (outcome 1)
Participants
19G FNA Needle: 36 started, 36 completed25G FNA Needle: 36 started, 36 completed
Serious adverse events
19G FNA Needle: 0 of 3625G FNA Needle: 0 of 36Participants with at least one serious adverse event, of those at risk, as posted
3 secondary outcomes
Procurement of Histological Samples
19G FNA Needle 86.1, n=36; 25G FNA Needle 33.3, n=36 [percentage of participants]
Needle Dysfunction
19G FNA Needle 0, n=36; 25G FNA Needle 2.8, n=36 [percentage of participants]
Complications
19G FNA Needle 2.8, n=36; 25G FNA Needle 0, n=36 [percentage of participants]

Every value is copied from the trial’s results record at ClinicalTrials.gov. “Statistically significant” describes the posted test only: it does not say which group did better, and nothing here is read from a paper.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

This study compares the 19G and 25G needles for procuring tissue samples from the pancreas during Endoscopic Ultrasound (EUS) procedures.

Detailed description public domain (ClinicalTrials.gov)

The study compares the median number of passes to establish a definitive diagnosis using the 19G or 25G needles. Also, the ability of both needles to procure a histological core tissue is assessed.

Posted results (ClinicalTrials.gov registry) · primary outcome public domain (ClinicalTrials.gov)

Median Number of Passes to Establish Diagnosis [5 months]. Median, No. of passes (Inter-Quartile Range). 19G FNA Needle (n=36): 1 (1 to 1); 25G FNA Needle (n=36): 1 (1 to 1).

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Procurement of Histological Samples [30 days]. Number, percentage of participants. 19G FNA Needle (n=36): 86.1; 25G FNA Needle (n=36): 33.3.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Needle Dysfunction [2 hours]. Number, percentage of participants. 19G FNA Needle (n=36): 0; 25G FNA Needle (n=36): 2.8.

Posted results (ClinicalTrials.gov registry) · secondary outcome public domain (ClinicalTrials.gov)

Complications [30 days]. Number, percentage of participants. 19G FNA Needle (n=36): 2.8; 25G FNA Needle (n=36): 0.